Written on the 11 April 2019 by Matt Ogg
Althea now has more staff in London than Melbourne, with expectations its expertise from Australia will bring an advantage over large competitors who have traditionally dealt with easier operating environments.
As a relative newcomer to the medicinal cannabis space that only supplied to four patients 11 months ago, Melbourne-based Althea Group (ASX: AGH) has quickly gone on to take a major share of the Australian market.
Althea managing director and founder Josh Fegan says Australia’s legislative framework is much more arduous than markets like Canada, but the situation has improved considerably over the past year.
On 4 April the company reported 511 patients using its service, who along with doctors can track product details and studies on its own web-based technology platform Althea Concierge.
Categories: National Headlines